UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its holdings in shares of Ambarella, Inc. (NASDAQ:AMBA - Free Report) by 2.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 652,355 shares of the semiconductor company's stock after selling 13,931 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 1.56% of Ambarella worth $47,452,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of AMBA. Vanguard Group Inc. lifted its position in Ambarella by 1.8% during the fourth quarter. Vanguard Group Inc. now owns 4,696,124 shares of the semiconductor company's stock valued at $341,596,000 after acquiring an additional 81,557 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in shares of Ambarella by 7.3% during the 4th quarter. The Manufacturers Life Insurance Company now owns 1,452,128 shares of the semiconductor company's stock valued at $105,628,000 after purchasing an additional 98,841 shares during the last quarter. Millennium Management LLC lifted its holdings in shares of Ambarella by 11.5% during the 4th quarter. Millennium Management LLC now owns 1,394,192 shares of the semiconductor company's stock valued at $101,414,000 after purchasing an additional 144,268 shares during the last quarter. William Blair Investment Management LLC boosted its position in shares of Ambarella by 8.9% in the 4th quarter. William Blair Investment Management LLC now owns 829,052 shares of the semiconductor company's stock worth $60,305,000 after purchasing an additional 68,044 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. purchased a new position in Ambarella during the 4th quarter worth $52,770,000. 82.09% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, VP Christopher Day sold 479 shares of the business's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $55.02, for a total transaction of $26,354.58. Following the completion of the sale, the vice president now directly owns 15,441 shares in the company, valued at approximately $849,563.82. The trade was a 3.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Christopher B. Paisley sold 500 shares of the company's stock in a transaction on Tuesday, March 25th. The stock was sold at an average price of $55.50, for a total transaction of $27,750.00. Following the sale, the director now directly owns 40,281 shares of the company's stock, valued at $2,235,595.50. The trade was a 1.23% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 9,328 shares of company stock worth $513,467. Company insiders own 5.30% of the company's stock.
Ambarella Trading Down 0.1%
Shares of Ambarella stock traded down $0.08 during trading hours on Wednesday, reaching $62.40. The stock had a trading volume of 658,554 shares, compared to its average volume of 698,977. Ambarella, Inc. has a twelve month low of $38.86 and a twelve month high of $85.15. The firm has a market capitalization of $2.65 billion, a PE ratio of -16.17 and a beta of 1.99. The stock's 50 day moving average is $51.24 and its 200 day moving average is $63.43.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the company. Stifel Nicolaus dropped their price target on Ambarella from $100.00 to $80.00 and set a "buy" rating on the stock in a research note on Thursday, April 17th. Needham & Company LLC upped their price target on shares of Ambarella from $100.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 27th. Rosenblatt Securities reiterated a "buy" rating and set a $100.00 price objective on shares of Ambarella in a research note on Thursday, February 27th. Morgan Stanley dropped their price objective on shares of Ambarella from $90.00 to $80.00 and set an "overweight" rating on the stock in a report on Tuesday. Finally, Wall Street Zen upgraded Ambarella from a "sell" rating to a "hold" rating in a research note on Friday, February 28th. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, Ambarella currently has an average rating of "Moderate Buy" and a consensus price target of $84.17.
Get Our Latest Analysis on AMBA
Ambarella Company Profile
(
Free Report)
Ambarella, Inc develops semiconductor solutions that enable high-definition (HD) and ultra HD compression, image signal processing, and artificial intelligence processing worldwide. The company's system-on-a-chip designs integrated HD video processing, image processing, artificial intelligence computer vision algorithms, audio processing, and system functions onto a single chip for delivering video and image quality, differentiated functionality, and low power consumption.
Further Reading

Before you consider Ambarella, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambarella wasn't on the list.
While Ambarella currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.